Cited by 127Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPersonality Disorders and Psychopathology

The DOI matches its Crossref record; 73 of the 75 references it cites were found in a registry or an index.

Emerging adult age status predicts poor buprenorphine treatment retention

Open access

Schuman-Olivier, Zev, Weiss, Roger D., Hoeppner, Bettina B., Borodovsky, Jacob, Albanese, Mark J.·2014·Journal of Substance Abuse Treatment

DOI 10.1016/j.jsat.2014.04.006PMC PMC4180514

Open this paper in CoChat — free account

Abstract

Emerging adults (18-25 years old) are often poorly retained in substance use disorder treatment. Office-based buprenorphine often enhances treatment retention among people with opioid dependence. In this study, we examined the records of a collaborative care buprenorphine treatment program to compare the treatment retention rates of emerging adults versus older adults. Subjects were 294 adults, 71 (24%) aged 18-25, followed in treatment with buprenorphine, nurse care management, and an intensive outpatient program followed by weekly psychosocial treatment. Compared to older adults, emerging adults remained in treatment at a significantly lower rate at 3 months (56% versus 78%) and 12 months (17% versus 45%), and were significantly more likely to test positive for illicit opioids, relapse, or drop out of treatment. Further research into factors associated with buprenorphine treatment retention among emerging adults is needed to improve treatment and long-term outcomes in this group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2014.04.006

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Emerging adulthood: A theory of development from the late teens through the twenties.
Arnett, J. J. (2000) · American Psychologist · doi:10.1037/0003-066x.55.5.469 · Cited by 16,843
Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1037/e560352009-001 · Cited by 6,930
Dynamic mapping of human cortical development during childhood through early adulthood
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent, T. F., Herman, D. H., Clasen, L. S., Toga, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402680101 · Cited by 5,604 · cited 2×
“…of cortical pruning and myelination needed for the development of executive function are underway during this time period (Giedd et al., 1999; Gogtay et al., 2004; Lebel & Beaulieu, 2011; Marsh, Gerber, & Peterson, 2008) and can be disrupted by substance abuse (Jacobus et al., 2009; Medina,…”
Background
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
The Epidemiologic Transition: A Theory of the Epidemiology of Population Change
Omran, A. R. (2005) · Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00398.x · Cited by 3,986
Why People Use Health Services
Rosenstock, I. M. (2005) · Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00425.x · Cited by 2,329
Why People Use Health Services
Rosenstock, I. M. (1966) · The Milbank Memorial Fund Quarterly · doi:10.2307/3348967 · Cited by 2,305
Monitoring the Future national survey results on drug use, 1975-2017: Volume I, secondary school students
Miech, R., Johnston, L. A., O'Malley, P., Bachman, J., Schulenberg, J., & Patrick, M. E. (2005) · doi:10.3998/2027.42/146530 · Cited by 1,771
Longitudinal Development of Human Brain Wiring Continues from Childhood into Adulthood
Lebel, C., & Beaulieu, C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5302-10.2011 · Cited by 1,193
The Developmental Context of Substance use in Emerging Adulthood
Arnett, J. J. (2005) · Journal of Drug Issues · doi:10.1177/002204260503500202 · Cited by 1,033

Show all 75 references

Sorted by citations

Medication-Assisted Treatment of Adolescents With Opioid Use Disorders
Ryan, S. A., Gonzalez, P. K., Patrick, S. W., Quigley, J. M., Siqueira, L. M., & Walker, L. R. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1893 · Cited by 224
Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder
Hadland, S. E., Bagley, S. M., Rodean, J., Silverstein, M., Levy, S., Larochelle, M. R., Samet, J. H., & Zima, B. T. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.2143 · Cited by 220
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
Krawczyk, N., Williams, A. R., Saloner, B. K., & Cerdá, M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108329 · Cited by 145
Substance Use Among College Students
Welsh, J. W., Shentu, Y., & Sarvey, D. B. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20180037 · Cited by 156
Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature
Lyons, R. M., Yule, A. M., Schiff, D. M., Bagley, S. M., & Wilens, T. E. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0013 · Cited by 116
Opioid Use Disorders
Sharma, B., Bruner, A. B., Barnett, G., & Fishman, M. J. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.03.002 · Cited by 112
A randomized controlled trial of buprenorphine taper duration among opioid‐dependent adolescents and young adults
Marsch, L. A., Moore, S. K., Borodovsky, J. T., Solhkhah, R., Badger, G. J., Semino, S. J., Jarrett, K., Condon, K. A. D., Rossettie, K., Vincent, P., et al. (2016) · Addiction · doi:10.1111/add.13363 · Cited by 97
Self-citation
Predictors of early dropout in outpatient buprenorphine/naloxone treatment
Marcovitz, D. E., McHugh, R. K., Volpe, J., Votaw, V. R., & Connery, H. S. (2016) · American Journal on Addictions · doi:10.1111/ajad.12414 · Cited by 92
Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research
Moningka, H., Lichenstein, S. D., Worhunsky, P. D., DeVito, E. E., Scheinost, D., & Yip, S. W. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0232-4 · Cited by 83
Youth and the Opioid Epidemic
Levy, S. (2019) · PEDIATRICS · doi:10.1542/peds.2018-2752 · Cited by 80
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
Frost, M. C., Lampert, H., Tsui, J. I., Iles-Shih, M., & Williams, E. C. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00266-2 · Cited by 82
Outcomes for Physicians With Opioid Dependence Treated Without Agonist Pharmacotherapy in Physician Health Programs
Merlo, L. J., Campbell, M. D., Skipper, G. E., Shea, C. L., & DuPont, R. L. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.02.004 · Cited by 77
Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review
Borodovsky, J. T., Levy, S., Fishman, M. J., & Marsch, L. A. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000388 · Cited by 70
Self-citation
Evidence-Based Treatment of Young Adults With Substance Use Disorders
Hadland, S. E., Yule, A. M., Levy, S., Hallett, E., Silverstein, M., & Bagley, S. M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-023523d · Cited by 70
Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
Bhatraju, E. P., Grossman, E., Tofighi, B., McNeely, J., DiRocco, D., Flannery, M., Garment, A. R., Goldfeld, K. S., Gourevitch, M. N., & Lee, J. D. (2017) · Addiction Science & Clinical Practice · doi:10.1186/s13722-017-0072-2 · Cited by 66
Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities
Marshall, B. D. L., Green, T. C., Yedinak, J. L., & Hadland, S. E. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.01.022 · Cited by 64
Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults
Viera, A., Bromberg, D. J., Whittaker, S., Refsland, B. M., Stanojlović, M., Nyhan, K., & Altice, F. L. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa001 · Cited by 62
Group-based treatment of opioid use disorder with buprenorphine: A systematic review
Sokol, R., LaVertu, A. E., Morrill, D., Albanese, C., & Schuman-Olivier, Z. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.11.003 · Cited by 50
Self-citation
"The Age of Feeling in-Between": Addressing Challenges in the Treatment of Emerging Adults With Substance Use Disorders
Bergman, B. G., Kelly, J. F., Nargiso, J. E., & McKowen, J. W. (2016) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2015.09.008 · Cited by 50
Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions
Chang, D. C., Klimas, J., Wood, E., & Fairbairn, N. S. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1399403 · Cited by 48
Grit in patients with substance use disorders
Griffin, M. L., McDermott, K. A., McHugh, R. K., Fitzmaurice, G. M., & Weiss, R. D. (2016) · American Journal on Addictions · doi:10.1111/ajad.12460 · Cited by 47
Self-citation
Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder
Fishman, M. J., Wenzel, K. R., Scodes, J. M., Pavlicová, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.07.038 · Cited by 46
MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
Schuman-Olivier, Z., Borodovsky, J. T., Steinkamp, J., Munir, Q., Butler, K., Greene, M. A., Goldblatt, J., Xie, H. Y., & Marsch, L. A. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0122-4 · Cited by 44
Self-citation
Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder
Schuman‐Olivier, Z., Greene, M. C., Bergman, B. G., & Kelly, J. F. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.09.009 · Cited by 42
Self-citation
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults
Welsh, J. W., Dennis, M. L., Funk, R. R., Mataczynski, M. J., & Godley, M. D. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108584 · Cited by 39
The effects of continuing care on emerging adult outcomes following residential addiction treatment
Bergman, B. G., Hoeppner, B. B., Nelson, L. M., Slaymaker, V. J., & Kelly, J. F. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.017 · Cited by 34
Self-citation
Investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review
Dalton, K., Bishop, L., & Darcy, S. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107005 · Cited by 35
A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders
Dayal, P., & Balhara, Y. P. S. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.06.004 · Cited by 34
Extended-release naltrexone for youth with opioid use disorder
Mitchell, S. G., Monico, L. B., Gryczynski, J., Fishman, M. J., O’Grady, K. E., & Schwartz, R. P. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108407 · Cited by 33
Ambivalence and stigma beliefs about medication treatment among young adults with opioid use disorder: A qualitative exploration of young adults’ perspectives
Bagley, S. M., Schoenberger, S. F., dellaBitta, V., Lunze, K., Barron, K., Hadland, S. E., & Park, T. W. (2023) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.08.026 · Cited by 33
Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder
Golan, O. K., Totaram, R., Perry, E. W., Fortson, K., Rivera-Atilano, R., Entress, R. M., Golan, M., Andraka‐Christou, B., Whitaker, D. J., & Pigott, T. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109445 · Cited by 34
Opioid Use Disorder Treatment Facilities With Programs for Special Populations
Hadland, S. E., Jent, V. A., Alinsky, R. H., Marshall, B. D. L., Mauro, P. M., & Cerdá, M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.03.022 · Cited by 32
Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York
Neighbors, C. J., Choi, S., Healy, S., Yerneni, R., Sun, T., & Shapoval, L. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-019-0215-4 · Cited by 30
Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment
Carlsen, S.-E. L., Lunde, L.-H., & Torsheim, T. (2020) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s221618 · Cited by 30
A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder
Azar, P., Wong, J. S. H., Jassemi, S., Moore, E. M., Vo, D. X., Nikoo, M., & Young, S. (2020) · American Journal on Addictions · doi:10.1111/ajad.13050 · Cited by 30
Emerging Adults in Inpatient Substance Use Treatment: A Prospective Cohort Study of Patient Characteristics and Treatment Outcomes
Andersson, H. W., Lauvsnes, A. D. F., & Nordfjærn, T. (2020) · European Addiction Research · doi:10.1159/000512156 · Cited by 30
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
Laffont, C. M., Ngaimisi, E., Gopalakrishnan, M., Ivaturi, V. D., Young, M. A., Greenwald, M. K., & Heidbreder, C. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1052113 · Cited by 30
Relapse Prevention Medications in Community Treatment for Young Adults with Opioid Addiction
Vo, H. T., Robbins, E., Westwood, M., Lezama, D., & Fishman, M. J. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1143435 · Cited by 29
Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine
Hui, D. S. C., Weinstein, Z., Cheng, D. M., Quinn, E. K., Kim, H. W., LaBelle, C. T., & Samet, J. H. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.05.010 · Cited by 28
Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment
Schuman‐Olivier, Z., Goodman, H., Rosansky, J. A., Fredericksen, A. K., Barria, J., Parry, G. J., Sokol, R. G., Gardiner, P. M., Cook, B. L., & Weiss, R. D. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54950 · Cited by 24
Self-citation
Assessment of a Naloxone Coprescribing Alert for Patients at Risk of Opioid Overdose: A Quality Improvement Project
Nelson, S. D., McCoy, A. B., Rector, H., Teare, A. J., Barrett, T. W., Sigworth, E. A., Chen, Q., Edwards, D. A., Marcovitz, D. E., & Wright, A. T. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005976 · Cited by 23
Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment with Buprenorphine: A Pilot Study
Suzuki, J., Zinser, J., Klaiber, B., Hannon, M., Grassi, H., Spinosa, M., Ramirez, A., Issa, M., & Feman, S. P. C. (2015) · Substance Abuse · doi:10.1080/08897077.2014.998400 · Cited by 22
Home-based delivery of XR-NTX in youth with opioid addiction
Vo, H. T., Burgower, R., Rozenberg, I., & Fishman, M. J. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.08.007 · Cited by 21
The Promise and Peril of Emerging Adulthood: Introduction to the Special Issue
Henin, A., & Berman, N. C. (2016) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2016.05.005 · Cited by 21
An Exploration of Young Adults With Opioid Use Disorder and How Their Perceptions of Family Members’ Beliefs Affects Medication Treatment
Bagley, S. M., Schoenberger, S. F., dellaBitta, V., Lunze, K., Barron, K., Hadland, S. E., & Park, T. W. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001001 · Cited by 21
Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders
O’Brien, P. L., Henke, R. M., Schaefer, M. B., Lin, J. R., & Creedon, T. B. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108555 · Cited by 19
Virtual Care in an Outpatient Subspecialty Substance Use Disorder Treatment Program
Levy, S., Deister, D., Fantegrossi, J., Green, L., Lunstead, J., Martinez, T., Riccardelli, W., Schizer, M. A., Schram, J., Schram, P., et al. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000871 · Cited by 19
Challenges and Gaps in Understanding Substance Use Problems in Transitional Age Youth
Bukstein, O. G. (2017) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.12.005 · Cited by 21
A systematic review of interventions to enhance initiation of and adherence to treatment for alcohol use disorders
Biswal, B., Bora, S., Anand, R., Bhatia, U., Fernandes, A., Joshi, M., & Nadkarni, A. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112429 · Cited by 20
Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention
Wenzel, K. R., Selby, V., Wildberger, J., Lavorato, L., Thomas, J. L., & Fishman, M. J. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108306 · Cited by 18
Integrating peer support services into primary care-based OUD treatment: Lessons from the Penn integrated model
Harris, R. A., Campbell, K., Calderbank, T., Dooley, P., Aspero, H., Maginnis, J., O'Donnell, N., Coviello, D., French, R., Bao, Y., et al. (2022) · Healthcare · doi:10.1016/j.hjdsi.2022.100641 · Cited by 17
HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
Page, K. A., Evans, J. L., Hahn, J. A., Vickerman, P. T., SHIBOSKI, S. C., & Morris, M. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226166 · Cited by 17
Integrating substance use care into primary care for adolescents and young adults: Lessons learned
Bagley, S. M., Hadland, S. E., Schoenberger, S. F., Gai, M. J., Topp, D., Hallett, E., Ashe, E. M., Samet, J. H., & Walley, A. Y. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108376 · Cited by 17
Treatment Trajectories During and After a Medication Trial for Opioid Use Disorder: Moving from Research as Usual to Treatment as Usual
Fishman, M. J., Vo, H. T., Burgower, R., Ruggiero, M. S., Rotrosen, J., Lee, J., & Nunes, E. V. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000592 · Cited by 17
Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities
Fishman, M. J., Wenzel, K. R., Gauthier, P. R., Borodovsky, J. T., Murray, O., Subramaniam, G., Levy, S., Fredyma, E., McLeman, B. M., & Marsch, L. A. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209352 · Cited by 16
Self-citation
A Review of Behavioral Therapies in Adolescents with Opioid Use Disorder
Welsh, J. W., Mataczynski, M. J., Nguyen, M. D., & McHugh, R. K. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000272 · Cited by 16
One-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine/Naloxone for the First Time in a Substance Treatment Unit
Mutlu, C., Demirci, A. Ç., Yalçın, Ö., Kılıçoğlu, A. G., Topal, M., & Karaçetin, G. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.04.002 · Cited by 16
Methadone Maintenance Treatment Discontinuation Among Young People who use Opioids in Vancouver, Canada
Pilarinos, A., Kwa, Y., Joe, R. S., Dong, H., Grant, C. C., Fast, D., Buxton, J. A., & DeBeck, K. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221136468 · Cited by 15
Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults
Choi, S., Biello, K. B., Bazzi, A. R., & Drainoni, M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.030 · Cited by 15
Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders
O’Brien, P. L., Henke, R. M., Schaefer, M. B., Lin, J. R., & Creedon, T. B. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108261 · Cited by 15
Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment
Justesen, K., Hooker, S. A., Sherman, M. D., Lonergan, M. E., Nissly, T. J., & Levy, R. J. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.06.200086 · Cited by 16
Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation
Sokol, R., Albanese, M., Chew, A., Early, J., Grossman, E., Roll, D., Sawin, G., Wu, D. J., & Schuman-Olivier, Z. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0176-y · Cited by 14
Self-citation
Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study
Fatkin, T., Moore, S. K., Okst, K., Creedon, T. B., Samawi, F., Fredericksen, A. K., Roll, D., Oxnard, A., Lê Cook, B., & Schuman-Olivier, Z. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108415 · Cited by 14
Self-citation
Interventions to Reduce Opioid Use in Youth At-Risk and in Treatment for Substance Use Disorders: A Scoping Review
Nairn, S. A., Audet, M., Stewart, S. H., Hawke, L. D., Isaacs, J. Y., Henderson, J. L., Haines‐Saah, R., Knight, R., Fast, D., Khan, F., et al. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221089810 · Cited by 14
College Student Preferences for Substance Use Disorder Educational Videos: A Qualitative Study
Andraka-Christou, B., Alex, B., & Lyneé Madeira, J. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1581816 · Cited by 13
A Phone Consultation Call Line to Support SBIRT in Pediatric Primary Care
Levy, S., Fuller, A., Kelly, S., Lunstead, J., Weitzman, E. R., & Straus, J. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.882486 · Cited by 13
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study
Hoffman, K., Peyton, M. L., & Sumner, M. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000301 · Cited by 13
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder
Barbosa‐Leiker, C., Campbell, A. N. C., Pavlicová, M., Scodes, J. M., Burlew, A. K., Hatch‐Maillette, M. A., Mennenga, S. E., Mitchell, S. G., Novo, P., Nunes, E. V., et al. (2020) · American Journal on Addictions · doi:10.1111/ajad.13059 · Cited by 13
Analysis of genetic and clinical factors associated with buprenorphine response
Crist, R. C., Vickers‐Smith, R., Kember, R. L., Rentsch, C. T., Xu, H., Edelman, E. J., Hartwell, E. E., Kampman, K. M., & Kranzler, H. R. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109013 · Cited by 12
Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management
Sidlak, A. M., Dibble, B., Dhaliwal, M., Bottone, P. D., Marino, R. T., Henry, L. L., & Howell, J. M. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111136 · Cited by 12
The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations
Marsch, L. A., Chen, C.-H., Adams, S. R., Asyyed, A. H., Does, M. B., Hassanpour, S., Hichborn, E. G., Jackson-Morris, M., Jacobson, N. C., Jones, H. K., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871916 · Cited by 12
Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People
Lillie, K., Shaw, J. L., Jansen, K. J., & Garrison, M. M. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000757 · Cited by 14
Evaluating substance use treatment efficacy for younger and older adults
Dingle, T., & Bowen, S. W. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106618 · Cited by 10
Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid‐related health problems: a population‐based retrospective cohort study
Paul, L. A., Bayoumi, A. M., Chen, C., Kocovska, E., Smith, B. T., Raboud, J., Gomes, T., Kendall, C., Rosella, L. C., Bitonti‐Bengert, L., et al. (2022) · Addiction · doi:10.1111/add.16096 · Cited by 9
Treatment Retention and Outcomes with the Adolescent Community Reinforcement Approach in Emerging Adults with Opioid Use
Welsh, J. W., Passetti, L. L., Funk, R. R., Smith, J. E., Meyers, R. J., & Godley, M. D. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1613585 · Cited by 9
Psychosocial Approaches in the Treatment of Opioid Use Disorders
Bergman, B. G., Fallah‐Sohy, N., Hoffman, L. A., & Kelly, J. F. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-16257-3_6 · Cited by 14
Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults
Peck, K. R., Ochalek, T. A., Badger, G. J., & Sigmon, S. C. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107879 · Cited by 9
Multidimensional Family Therapy for Justice-Involved Young Adults with Substance Use Disorders
Liddle, H. A., Dakof, G. A., Rowe, C. L., Mohamed, A. S., Henderson, C. E., Foulkrod, T., Lucas, M., & DiFrancesco, M. (2023) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-023-09852-5 · Cited by 8
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial
Fishman, M. J., Wenzel, K. R., Scodes, J. M., Pavlicová, M., Campbell, A. N. C., Rotrosen, J., & Nunes, E. V. (2021) · American Journal on Addictions · doi:10.1111/ajad.13176 · Cited by 8
Testing a Matching Hypothesis for Emerging Adults in Project MATCH: During-Treatment and One-Year Outcomes
Davis, J. P., Bergman, B. G., Smith, D. C., & Kelly, J. F. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.140 · Cited by 8
Medication Treatment for Opioid-Addicted Youth—What Are We Waiting for?
WOODY, G. E., & Fishman, M. J. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.04.002 · Cited by 7
Risk Factors for Treatment Drop-Out: Implications for Adverse Outcomes When Treating Opioid Use Disorder
Iovine, P. A., Drachman, D., & Kirane, H. (2020) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2020.1838859 · Cited by 6
Foundations of addictive problems in adolescents: Developmental and social factors
Preyde, M., Furtado, J., Head, S., & Long, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818626-8.00001-3 · Cited by 6
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults
Welsh, J. W., Krishnan, S. D., & Terranella, A. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01638-0 · Cited by 5
Implementation outcomes from a pilot study of training probation officers to deliver contingency management for emerging adults with substance use disorders
Drazdowski, T. K., Kelton, K., Hibbard, P. F., McCart, M. R., Chapman, J. E., de Martell, S. C., & Sheidow, A. J. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209450 · Cited by 5
Default Mode Network Functional Reorganization During Early Abstinence in Polysubstance-Using Emerging Adults Treated for Opioid Dependence
Copersino, M. L., Price, J. S., Frost, K. H., Vitaliano, G. D., Frederick, B. B., Lukas, S. E., Weiss, R. D., & Janes, A. C. (2016) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15090240 · Cited by 5
Self-citation
Treatment Retention in Opioid Dependent Clients Receiving Medication-Assisted Treatment: Six-Month Rate and Baseline Correlates
Fendrich, M., Becker, J., Ives, M. L., Rodis, E., & Marin, M. C. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1906276 · Cited by 5
Using the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) to Predict Gambling Disorder Among U.S. College Students
Qeadan, F., Egbert, J., Tingey, B., Plum, A., & Pasewark, T. (2024) · Journal of Gambling Studies · doi:10.1007/s10899-024-10283-w · Cited by 5
Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference
Armstrong, C., Ferrante, J. R., Lamichhane, N., Gamard, C., Reavis, Z., Walker, Q. D., Zucker, N., Patkar, A., & Kuhn, C. M. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173485 · Cited by 4
Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults
Aleksanyan, J., Choi, S., Lincourt, P., Burke, C., Ramsey, K. S., Hussain, S., Jordan, A. E., Morris, M., D’Aunno, T. A., Glied, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297567 · Cited by 4
Understanding the needs of postpartum emerging adults with substance use disorders to improve recovery supports
Cioffi, C. C., Lewis, L. F., & Gau, J. M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1521093 · Cited by 3
The role of polysubstance use in the development, maintenance, and treatment of stimulant use disorders
Rough, M. I., & Nader, M. A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100119 · Cited by 3
Higher perceived stress during admission is associated with shorter retention in short-term residential substance use disorder treatment
Ware, O. D., Sacco, P., Cagle, J. G., Frey, J. J., Wagner, F. A., Wimberly, A. S., Gyebi-Foster, B., Diaz, M., Peters, K., & Zemore, S. E. (2023) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2023.100502 · Cited by 4
Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural Settings
Flores, J. M., Kan, E., Mooney, L. J., Pham, H., Zhu, Y., Wolitzky-Taylor, K. B., & Hser, Y. (2024) · JAACAP Open · doi:10.1016/j.jaacop.2024.02.001 · Cited by 3
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Miller, E. A., McGinnis, K. A., Edelman, E. J., Feinberg, T., Gordon, K. S., Kerns, R. D., Marshall, B. D. L., Patterson, J. A., & McRae, M. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04494-w · Cited by 3
Organization of primary care and early MOUD discontinuation
Harris, R. A., Kearney, M., Keddem, S., Calderbank, T., Tomczuk, L., Clapp, J. T., Perrone, J., Kranzler, H. R., Long, J. A., & Mandell, D. S. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00527-w · Cited by 3
Legal involvement and substance use treatment engagement and outcomes
Carter, A. C., & Dennis, C. B. (2021) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2021.1988492 · Cited by 3
The Broken Care Continuum for Young Adults With Opioid Addiction
Hadland, S. E. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.09.020 · Cited by 3
Gone Too Soon: Higher Pretreatment and Treatment Dropout Among Emerging Adults in a Women‐Specific Outpatient Treatment Service for Substance Use Disorders in Brazil
Borges, I. E. L., Stafuzza, G. D. R., Tótolo, P. L. F., Gomes, M. N. S., Cavalcante, E. J., Suen, P. J. C., dos Santos, A. A. M., Pan, P. M., Brasiliano, S., Hochgraf, P. B., et al. (2026) · Early Intervention in Psychiatry · doi:10.1111/eip.70133 · Cited by 2
Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
Janzow, G. E., Harding, C., Flores, M. W., Borodovsky, J. T., Steinkamp, J., Marsch, L. A., & Schuman‐Olivier, Z. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100045 · Cited by 2
Self-citation

Authors: Schuman-Olivier, Z., Weiss, R. D., Hoeppner, B. B., Borodovsky, J., & Albanese, M. J.
Affiliations: Harvard University (US)
Cambridge Health Alliance (US)
ORCID: Schuman-Olivier, Zev
Weiss, Roger D.
Hoeppner, Bettina B.
Borodovsky, Jacob
Venue: Journal of Substance Abuse Treatment
Publisher: Elsevier BV
Published: 2014-09
Volume: 47
Issue: 3
Pages: 202-212
ISSN: 0740-5472 (ISSN-L)
DOI: 10.1016/j.jsat.2014.04.006
PMC: PMC4180514
OpenAlex: W2164375280
Cited by: 127
References: 75
Citations by year: 2026: 10 · 2025: 8 · 2024: 13 · 2023: 3 · 2022: 15 · 2021: 17 · 2020: 22 · 2019: 11 · 2018: 4 · 2017: 8 · 2016: 12 · 2015: 3 · 2014: 1
FWCI: 7.96
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Substance Abuse Treatment (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Substance Abuse and Mental Health Services Administration
National Institute on Drug Abuse (K24DA022288, L30 DA027330, K01DA027097, U10DA015831, U10-DA15831)
National Center for Research Resources (UL1RR025758)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords: emerging adults, buprenorphine, treatment retention, opioid use disorder, addiction treatment, collaborative care, nursing care management, intensive outpatient treatment, relapse, treatment discontinuation, age differences
MeSH terms: Adolescent, Adult, Aging, Buprenorphine, Female, Humans, Male, Narcotic Antagonists, Opioid-Related Disorders, Patient Compliance, Patient Dropouts, Recurrence, Retrospective Studies, Substance Abuse Detection, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emerging adult age status predicts poor buprenorphine treatment retention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks